LabGenomics Co., Ltd. (KOSDAQ:084650)

Market Cap	163.70B
Revenue (ttm)	87.97B
Net Income (ttm)	-35.04B
Shares Out	74.24M
EPS (ttm)	-472.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	428,403
Average Volume	1,190,339
Open	2,215.00
Previous Close	2,205.00
Day's Range	2,210.00 - 2,245.00
52-Week Range	1,991.00 - 3,915.00
Beta	-0.10
RSI	46.01
Earnings Date	Nov 14, 2025

About LabGenomics

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2002
• Employees: 143
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084650

Financial Performance

In 2024, LabGenomics's revenue was 85.90 billion, an increase of 20.85% compared to the previous year's 71.08 billion. Losses were -23.80 billion, 409.1% more than in 2023.